Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Cannabis reduction is associated with functional improvement, but reduction endpoints have …
Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.
Reduction-based cannabis use endpoints are needed to better evaluate treatments for
cannabis use disorder (CUD). This exploratory, secondary analysis aimed to characterize …
cannabis use disorder (CUD). This exploratory, secondary analysis aimed to characterize …
Treatment of cannabis use disorder: current science and future outlook
BJ Sherman, AL McRae‐Clark - Pharmacotherapy: The Journal …, 2016 - Wiley Online Library
Cannabis is the most commonly used illicit substance in the United States. Rates of
cannabis use and cannabis use disorder (CUD) have increased in the past decade …
cannabis use and cannabis use disorder (CUD) have increased in the past decade …
Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders
EN Peters, C Nich, KM Carroll - Drug and Alcohol Dependence, 2011 - Elsevier
BACKGROUND: While several randomized controlled trials evaluating a range of treatments
for cannabis use disorders have appeared in recent years, these have been marked by …
for cannabis use disorders have appeared in recent years, these have been marked by …
Non-abstinent treatment outcomes for cannabis use disorder
Background Abstinence remains a standard outcome for potential treatment interventions for
Cannabis Use Disorder (CUD). However, there needs to be validation of non-abstinent …
Cannabis Use Disorder (CUD). However, there needs to be validation of non-abstinent …
Measuring within-individual cannabis reduction in clinical trials: a review of the methodological challenges
Abstract Purpose of Review Cannabis abstinence, traditionally, is the primary outcome in
cannabis use disorder (CUD) treatment trials. Due to the changing legality of cannabis …
cannabis use disorder (CUD) treatment trials. Due to the changing legality of cannabis …
Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder
Cannabis use disorder (CUD) is prevalent and demand for treatment is increasing, yet few
individuals engage in formal treatment and the efficacy of established interventions for CUD …
individuals engage in formal treatment and the efficacy of established interventions for CUD …
Cessation of cannabis use: A retrospective cohort study
AK Seidel, A Pedersen, R Hanewinkel… - Psychiatry …, 2019 - Elsevier
Given recent findings of a worldwide increase in cannabis use, a better understanding of the
factors associated with cannabis use is needed. Most previous studies have focused on …
factors associated with cannabis use is needed. Most previous studies have focused on …
Psychosocial and pharmacological interventions for the treatment of cannabis use disorder
P Sabioni, B Le Foll - FOCUS, A Journal of the American …, 2019 - Am Psychiatric Assoc
Cannabis use has been continuously increasing, and cannabis use disorder (CUD) has
become a public health issue. Some psychosocial interventions have demonstrated the …
become a public health issue. Some psychosocial interventions have demonstrated the …
Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study
EA McClure, NL Baker, SC Sonne, UE Ghitza… - Drug and alcohol …, 2018 - Elsevier
Background It is common for cannabis users to also use tobacco. While data suggest that
tobacco users have more difficulty achieving cannabis cessation, secondary analyses of …
tobacco users have more difficulty achieving cannabis cessation, secondary analyses of …